662 related articles for article (PubMed ID: 24269664)
21. Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-D-aspartate receptor antagonist MK-801 in mice.
Dall'Igna OP; Da Silva AL; Dietrich MO; Hoffmann A; de Oliveira RV; Souza DO; Lara DR
Psychopharmacology (Berl); 2003 Mar; 166(3):258-63. PubMed ID: 12589526
[TBL] [Abstract][Full Text] [Related]
22. Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism.
Neill JC; Barnes S; Cook S; Grayson B; Idris NF; McLean SL; Snigdha S; Rajagopal L; Harte MK
Pharmacol Ther; 2010 Dec; 128(3):419-32. PubMed ID: 20705091
[TBL] [Abstract][Full Text] [Related]
23. Persisting cognitive deficits induced by low-dose, subchronic treatment with MK-801 in adolescent rats.
Li JT; Su YA; Guo CM; Feng Y; Yang Y; Huang RH; Si TM
Eur J Pharmacol; 2011 Feb; 652(1-3):65-72. PubMed ID: 21114996
[TBL] [Abstract][Full Text] [Related]
24. Lurasidone reverses MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze tests in rats.
Enomoto T; Ishibashi T; Tokuda K; Ishiyama T; Toma S; Ito A
Behav Brain Res; 2008 Jan; 186(2):197-207. PubMed ID: 17881065
[TBL] [Abstract][Full Text] [Related]
25. The nicotinic α7 receptor agonist GTS-21 improves cognitive performance in ketamine impaired rhesus monkeys.
Cannon CE; Puri V; Vivian JA; Egbertson MS; Eddins D; Uslaner JM
Neuropharmacology; 2013 Jan; 64():191-6. PubMed ID: 22659472
[TBL] [Abstract][Full Text] [Related]
26. Towards an animal model of an antipsychotic drug-resistant cognitive impairment in schizophrenia: scopolamine induces abnormally persistent latent inhibition, which can be reversed by cognitive enhancers but not by antipsychotic drugs.
Barak S; Weiner I
Int J Neuropsychopharmacol; 2009 Mar; 12(2):227-41. PubMed ID: 18687163
[TBL] [Abstract][Full Text] [Related]
27. Synergistic effect of combined treatment with risperidone and galantamine on phencyclidine-induced impairment of latent visuospatial learning and memory: Role of nAChR activation-dependent increase of dopamine D1 receptor-mediated neurotransmission.
Wang D; Noda Y; Zhou Y; Nitta A; Furukawa H; Nabeshima T
Neuropharmacology; 2007 Sep; 53(3):379-89. PubMed ID: 17632185
[TBL] [Abstract][Full Text] [Related]
28. Effects of cariprazine, a novel antipsychotic, on cognitive deficit and negative symptoms in a rodent model of schizophrenia symptomatology.
Neill JC; Grayson B; Kiss B; Gyertyán I; Ferguson P; Adham N
Eur Neuropsychopharmacol; 2016 Jan; 26(1):3-14. PubMed ID: 26655189
[TBL] [Abstract][Full Text] [Related]
29. The mGlu₅ positive allosteric modulator LSN2463359 differentially modulates motor, instrumental and cognitive effects of NMDA receptor antagonists in the rat.
Gastambide F; Gilmour G; Robbins TW; Tricklebank MD
Neuropharmacology; 2013 Jan; 64():240-7. PubMed ID: 22884612
[TBL] [Abstract][Full Text] [Related]
30. A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease.
Harada K; Nakato K; Yarimizu J; Yamazaki M; Morita M; Takahashi S; Aota M; Saita K; Doihara H; Sato Y; Yamaji T; Ni K; Matsuoka N
Eur J Pharmacol; 2012 Jun; 685(1-3):59-69. PubMed ID: 22542656
[TBL] [Abstract][Full Text] [Related]
31. Kami-ondam-tang, a traditional herbal prescription, attenuates the prepulse inhibition deficits and cognitive impairments induced by MK-801 in mice.
Oh HK; Park SJ; Bae SG; Kim MJ; Jang JH; Ahn YJ; Woo H; Kwon G; Ryu JH
J Ethnopharmacol; 2013 Mar; 146(2):600-7. PubMed ID: 23376282
[TBL] [Abstract][Full Text] [Related]
32. Putative cognitive enhancers in preclinical models related to schizophrenia: the search for an elusive target.
Barak S; Weiner I
Pharmacol Biochem Behav; 2011 Aug; 99(2):164-89. PubMed ID: 21420999
[TBL] [Abstract][Full Text] [Related]
33. A two-hit model: behavioural investigation of the effect of combined neonatal MK-801 administration and isolation rearing in the rat.
Lim AL; Taylor DA; Malone DT
J Psychopharmacol; 2012 Sep; 26(9):1252-64. PubMed ID: 22361477
[TBL] [Abstract][Full Text] [Related]
34. The Influence of the CB1 Receptor Ligands on the Schizophrenia-Like Effects in Mice Induced by MK-801.
Kruk-Slomka M; Budzynska B; Slomka T; Banaszkiewicz I; Biala G
Neurotox Res; 2016 Nov; 30(4):658-676. PubMed ID: 27577742
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory avoidance memory deficit induced by scopolamine: Interaction of cholinergic and glutamatergic systems in the ventral tegmental area.
Mahmoodi G; Ahmadi S; Pourmotabbed A; Oryan S; Zarrindast MR
Neurobiol Learn Mem; 2010 Jul; 94(1):83-90. PubMed ID: 20403448
[TBL] [Abstract][Full Text] [Related]
36. Reversal of PCP-induced learning and memory deficits in the Morris' water maze by sertindole and other antipsychotics.
Didriksen M; Skarsfeldt T; Arnt J
Psychopharmacology (Berl); 2007 Aug; 193(2):225-33. PubMed ID: 17406859
[TBL] [Abstract][Full Text] [Related]
37. GluN2C/GluN2D subunit-selective NMDA receptor potentiator CIQ reverses MK-801-induced impairment in prepulse inhibition and working memory in Y-maze test in mice.
Suryavanshi PS; Ugale RR; Yilmazer-Hanke D; Stairs DJ; Dravid SM
Br J Pharmacol; 2014 Feb; 171(3):799-809. PubMed ID: 24236947
[TBL] [Abstract][Full Text] [Related]
38. Improving cognition in schizophrenia with antipsychotics that elicit neurogenesis through 5-HT(1A) receptor activation.
Schreiber R; Newman-Tancredi A
Neurobiol Learn Mem; 2014 Apr; 110():72-80. PubMed ID: 24423786
[TBL] [Abstract][Full Text] [Related]
39. Memory-enhancing treatments do not reverse the impairment of inhibitory avoidance retention induced by NMDA receptor blockade.
Roesler R; Vianna MR; de-Paris F; Quevedo J
Neurobiol Learn Mem; 1999 Nov; 72(3):252-8. PubMed ID: 10536102
[TBL] [Abstract][Full Text] [Related]
40. Nicotine improves ethanol-induced memory impairment: the role of dorsal hippocampal NMDA receptors.
Rezayof A; Shirazi-Zand Z; Zarrindast MR; Nayer-Nouri T
Life Sci; 2010 Feb; 86(7-8):260-6. PubMed ID: 20035769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
